Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS1(16-42) antigen

Despite the availability of improved antiviral therapies, infection with Hepatitis B virus (HBV) remains a3 significant health issue, as a curable treatment is yet to be discovered. Current HBV vaccines relaying on the efficient expression of the small (S) envelope protein in yeast and the implement...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantazica, Ana-Maria, Dobrica, Mihaela-Olivia, Lazar, Catalin, Scurtu, Cristina, Tucureanu, Catalin, Caras, Iuliana, Ionescu, Irina, Costache, Adriana, Onu, Adrian, Clarke, Jihong Liu, Stavaru, Crina, Branza-Nichita, Norica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354405/
https://www.ncbi.nlm.nih.gov/pubmed/35935966
http://dx.doi.org/10.3389/fimmu.2022.941243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354405/
https://www.ncbi.nlm.nih.gov/pubmed/35935966
http://dx.doi.org/10.3389/fimmu.2022.941243

Ejemplares similares